Skeletal-related events in urological cancer patients with bone metastasis: A multicenter study in Japan

International Journal of Urology

Volumn 17, Issue 4, 2010, Pages 332-336

  Yokomizo, Akira ^a   Koga, Hirofumi ^b   Shinohara, Nobuo ^d   Miyahara, Tsukasa ^c   MacHida, Noriko ^e   Tsukino, Hiromasa ^f   Uozumi, Jiro ^g   Nishiyama, Kenryu ^h   Satoh, Fuminori ⁱ   Sakai, Hideki ^j   Naito, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f UNIVERSITY OF MIYAZAKI   (Japan)

^g SAGA UNIVERSITY   (Japan)

^h KAGOSHIMA UNIVERSITY   (Japan)

ⁱ OITA UNIVERSITY   (Japan)

^j NAGASAKI UNIVERSITY   (Japan)

more..

Author keywords

Bone metastasis; Prostate cancer; Renal cell carcinoma; Skeletal related events; Urothelial cancer

Indexed keywords

ARTICLE; BLADDER CANCER; BONE DISEASE; BONE METASTASIS; BONE PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISTANT METASTASIS; FEMALE; FRACTURE; HUMAN; INCIDENCE; JAPAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; SPINAL CORD COMPRESSION; URINARY TRACT CANCER;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; JAPAN; MALE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UROLOGIC NEOPLASMS;

EID: 77949908342     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02468.x     Document Type: Article

References (12)

1. Saad F, Gleason DM, Murray R et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J. Natl. Cancer Inst. 2002 94 : 1458 1468.
2. Lipton A, Zheng M, Seaman J. Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer 2003 98 : 962 969.
3. Berenson JR, Lichtenstein A, Porter L et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N. Engl. J. Med. 1996 334 : 488 493.
4. Hortobagyi GN, Theriault RL, Lipton A et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J. Clin. Oncol. 1998 16 : 2038 2044.
5. Theriault RL, Lipton A, Hortobagy GN et al. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J. Clin. Oncol. 1999 17 : 846 854.
6. Kylmälä T, Taube T, Tammela TL, Risteli L, Risteli J, Elomaa I. Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer. Br. J. Cancer 1997 76 : 939 942.
7. Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J. Clin. Oncol. 2003 21 : 4277 4284.
8. Lipton A, Cook R, Saad F et al. Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer 2008 113 : 193 201.
9. Saad F, Karakiewicz P, Perrotte P. The role of bisphosphonates in hormone-refractory prostate cancer. World J. Urol. 2005 23 : 14 8.
10. Cabinet Office, Government of Japan. The State of Aging and Implementation of Measures for an Aging Society in FY 2006. In : WHITE PAPER ON THE AGING SOCIETY (SUMMARY) FY 2007. The paper presented by Cabinet Office, Government of Japan. [Cited 1 March 2009.] Available from URL: http://www8.cao.go.jp/kourei/english/annualreport/2007/2007.pdf
11. Yasui T, Uemura H, Irahara M et al. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women. Clin. Chim. Acta 2008 398 : 43 7.
12. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. A population-level decline in serum testosterone levels in American men. J. Clin. Endocrinol. Metab. 2007 92 : 196 202.